Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

277 studies match

clinicaltrialsPublishedShowing 251–277 of 277 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01937689	Study of Pyrotinib in Patients With Human Epidermalgrowth Factor Receptor 2 (HER2) Positive Advanced Breast Cancer	completed	Phase 1	40	Jiangsu HengRui Medicine Co., Ltd.INDUSTRY	1	Jul 9, 2018	clinicaltrials
NCT02361112	Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer(BLTN-Ic)	completed	Phase 1	38	Jiangsu HengRui Medicine Co., Ltd.INDUSTRY	1